Summary
Guardant Health, Inc. (GH) filed an 8-K on February 23, 2022, primarily to announce their financial results for the fiscal quarter and year ended December 31, 2021. While the filing itself does not contain detailed financial figures, it incorporates by reference a press release (Exhibit 99.1) which contains the comprehensive results. Investors should refer to this press release for specific revenue, net income, loss per share, and other key performance indicators. The 8-K filing indicates that the information provided is furnished, not filed, meaning it is not subject to the same liability under Section 18 of the Exchange Act, though it may be incorporated into future SEC filings. The focus of this filing is to provide timely information to the market regarding the company's most recent financial performance. The press release, which is the core of the disclosure, would detail the company's operational and financial standing, including any forward-looking guidance or significant business updates that occurred during or were announced at the time of the earnings release. Investors seeking a thorough understanding of Guardant Health's financial health and future outlook should consult the referenced press release for a complete picture of the reported results.
Key Highlights
- 1Guardant Health announced financial results for the fiscal quarter and year ended December 31, 2021, via an 8-K filing.
- 2The detailed financial results are contained within the press release furnished as Exhibit 99.1 to the 8-K.
- 3This filing serves as an announcement mechanism for the company's latest financial performance.
- 4Investors are directed to the press release for specific financial data and performance metrics.
- 5The information furnished in the 8-K is not considered 'filed' for the purposes of Section 18 of the Exchange Act.
- 6Exhibit 99.1, the press release, is the primary source of information for investors regarding the reported financial results.